E Fund Management Co., Ltd. Summit Therapeutics Inc. Transaction History
E Fund Management Co., Ltd.
- $1.93 Billion
- Q3 2024
A detailed history of E Fund Management Co., Ltd. transactions in Summit Therapeutics Inc. stock. As of the latest transaction made, E Fund Management Co., Ltd. holds 281,105 shares of SMMT stock, worth $6.17 Million. This represents 0.32% of its overall portfolio holdings.
Number of Shares
281,105
Previous 10,076
2689.85%
Holding current value
$6.17 Million
Previous $78,000
7792.31%
% of portfolio
0.32%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding SMMT
# of Institutions
201Shares Held
76.4MCall Options Held
2.01MPut Options Held
2.83M-
Baker Bros. Advisors LP New York, NY24.4MShares$536 Million5.73% of portfolio
-
Vanguard Group Inc Valley Forge, PA10.9MShares$240 Million0.0% of portfolio
-
Black Rock Inc. New York, NY7.9MShares$173 Million0.0% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD5.44MShares$119 Million0.01% of portfolio
-
State Street Corp Boston, MA3.47MShares$76.1 Million0.0% of portfolio
About Summit Therapeutics Inc.
- Ticker SMMT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 201,215,008
- Market Cap $4.42B
- Description
- Summit Therapeutics Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat infectious diseases in the United States and Latin America. It conducts clinical programs focusing on Clostridioides difficile infection (CDI). The company's lead product candidate is ridinilazole, an orally administered small molecu...